RecruitingPhase 4NCT06752863

Labetalol Infusion and Dexmedetomidine Infusion in Hypotensive Anesthesia

Comparative Study of Labetalol Infusion Versus Dexmedetomidine Infusion in Hypotensive Anesthesia in Ear, Nose and Throat Surgeries

Sponsor

Ain Shams University

Enrollment

80 participants

Start Date

Nov 27, 2024

Study Type

INTERVENTIONAL

Conditions

Hypotensive Anesthesia Ear, Nose and Throat Procedure

Summary

this study aims to compare between the role of Labetalol infusion versus Dexmedetomidine infusion in hypotensive anesthesia in Ear, Nose and Throat surgeries.

Eligibility

Min Age: 20 YearsMax Age: 50 Years

Inclusion Criteria2

American Society of Anesthesiologists I, II (ASA I, II) patients who were candidate for Ear, Nose and Throat surgeries.
Age: between 20 and 50 years

Exclusion Criteria5

Patients with uncontrolled hypertension, variable degrees of heart block, congestive cardiac failure, coagulopathy, cerebral insufficiency, hepatic or renal abnormality
Patients on beta blocker or clonidine
Pregnant or lactating females
Patients who were allergic to any of the anesthetic or hypotensive drugs used in the study
Patient refusal to be included in the trial

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGHypotensive anesthesia in ear, nose and throat surgeries using labetalol and dexmedetomidine infusions

The study compares the role of Labetalol infusion versus Dexmedetomidine infusion in hypotensive anesthesia in patients having ear, nose and throat surgeries

Locations(1)

Ain Shams university

Cairo, Cairo Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06752863